Yuming Hu

Yuming Hu

Mr

 https://orcid.org/0009-0005-9749-0329

Personal profile

Overview

I am currently a first-year PhD student funded by MRC in Maternal and Fetal Health Research Centre at the University of Manchester. During my PhD, we mainly look into drug transfer through placenta and beta blocker's impact on fetal growth. Main methodology includes animal study, ex-vivo placenta perfusion system and physiologically based pharmacokinetic model.

I am also an alumni from Model-based Drug Development MSc at the University of Manchester, where I was trained in population pharmacokinetic modelling and physiologically based pharmacokinetic modelling. One and a half years' industrial experience followed in the field of quantitative pharmacology.

Research interests

My PhD topic is: A comparative study of maternal cardioprotective therapy with bisoprolol and nebivolol in humans and rat: application of maternal-fetal PBPK modelling for prediction of human fetal beta-1 blocker exposure 

My group

My PhD is supervised by Teresa Tropea, Elizabeth Cottrell, Paul Brownbill (Maternal and Fetal Health Research Centre) and Daniel Scotcher (Centre of Applied Pharmacokinetic Research).

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Master in Science, Model-Based Drug Development, The University of Manchester

29 Sept 2022 → 23 Sept 2023

Award Date: 27 Nov 2023

Bachelor of Science, Pharmaceutical Science, Fudan University

15 Sept 2017 → 15 Jun 2022

Award Date: 15 Jun 2022

Fingerprint

Dive into the research topics where Yuming Hu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint